Platelet response heterogeneity in thrombus formation

Journal:Thrombosis and Haemostasis
ISSN:0340-6245
DOI:http://dx.doi.org/10.1160/TH09-05-0289
Issue:2009: 102/6 (Dec) pp. 1007–1291
Pages:1149-1156

Platelet response heterogeneity in thrombus formation

Imke C. A. Munnix1*; Judith M. E. M. Cosemans1*; Jocelyn M. Auger2; Johan W. M. Heemskerk1

1Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands; 2Centre for Cardiovascular Sciences Institute of Biomedical Research, University of Birmingham, Birmingham, United Kingdom

Summary

Vascular injury leads to formation of a structured thrombus as a consequence of platelet activation and aggregation, thrombin and fibrin formation, and trapping of leukocytes and red cells. This review summarises current evidence for heterogeneity of platelet responses and functions in the thrombus-forming process. Environmental factors contribute to response heterogeneity, as the platelets in a thrombus adhere to different substrates, and sense specific (ant)agonists and rheological conditions. Contraction of platelets and interaction with fibrin and other blood cells cause further response variation. On the other hand, response heterogeneity can also be due to intrinsic differences between platelets in age and in receptor and signalling proteins. As a result, at least three subpopulations of platelets are formed in a thrombus: aggregating platelets with (reversible) integrin activation, procoagulant (coated) platelets exposing phosphatidylserine and binding coagulation factors, and contracting platelets with cell-cell contacts. This recognition of thrombus heterogeneity has implications for the use and development of antiplatelet medication.

Keywords

coagulation, Platelets, aggregation, Heterogeneity, thrombus formation

DOI

http://dx.doi.org/10.1160/TH09-05-0289

You may also be interested in...

1.

Ruben G. Xavier, Ann E. White, Susan C. Fox, Robert G. Wilcox, Stan Heptinstall

Thrombosis and Haemostasis 2007 98 6: 1266-1275

http://dx.doi.org/10.1160/TH07-03-0189

2.

Aicha Bouaziz1, Nidhal Ben Amor1, Geoffrey E. Woodard2, Hanen Zibidi1, José J. López3, Ahgleb Bartegi1, Ginés M. Salido3, Juan A. Rosado3

Thrombosis and Haemostasis 2007 98 2: 375-384

http://dx.doi.org/10.1160/TH07-01-0061

3.

M. Urooj Zafar1, Michael E. Farkouh1, Julio Osende1, Daichi Shimbo1, Stella Palencia1, Julia Crook2, Robert Leadley3, Valentin Fuster1, James H. Chesebro2

Thrombosis and Haemostasis 2007 97 3: 487-492

http://dx.doi.org/10.1160/TH06-04-0188



Articles

You've 106 Article(s) in your Basket.

TH 107.5

Clinical Focus on GPIIb/IIIa inhibitors: In the May issue of Thrombosis and Haemostasis Armstrong...

TH 107.4

The April 2012 issue of Thrombosis and Haemostasis TH 107.4 is a Theme Issue by A. Schober, T....

Thrombosis and Haemostasis official organ of Spanish Society for Thrombosis and Haemostasis

Thrombosis and Haemostasis, founded in 1957, has become the official organ of the Spanish Society...